ConvaTec Group PLC (CTEC) Receives GBX 312.33 Consensus Price Target from Brokerages
Shares of ConvaTec Group PLC (LON:CTEC) have been given a consensus rating of “Buy” by the ten analysts that are covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and six have assigned a buy rating to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is GBX 312.33 ($4.05).
A number of equities research analysts recently weighed in on CTEC shares. Deutsche Bank AG restated a “buy” rating and set a GBX 330 ($4.28) price objective on shares of ConvaTec Group PLC in a research note on Monday, July 31st. Peel Hunt reiterated a “buy” rating and issued a GBX 380 ($4.93) price target on shares of ConvaTec Group PLC in a research report on Thursday, July 20th. Goldman Sachs Group, Inc. (The) reiterated a “buy” rating and issued a GBX 340 ($4.41) price target on shares of ConvaTec Group PLC in a research report on Friday, June 30th. Finally, HSBC Holdings plc reiterated a “buy” rating and issued a GBX 330 ($4.28) price target on shares of ConvaTec Group PLC in a research report on Wednesday, April 26th.
Shares of ConvaTec Group PLC (CTEC) traded down 0.75% during trading on Friday, hitting GBX 290.00. 3,423,378 shares of the stock were exchanged. The stock has a 50-day moving average of GBX 305.39 and a 200 day moving average of GBX 288.08. ConvaTec Group PLC has a 12-month low of GBX 213.00 and a 12-month high of GBX 349.10. The stock’s market cap is GBX 5.66 billion.
The firm also recently declared a dividend, which will be paid on Friday, October 20th. Shareholders of record on Thursday, September 7th will be given a GBX 1.06 ($0.01) dividend. This represents a yield of 0.36%. The ex-dividend date is Thursday, September 7th.
About ConvaTec Group PLC
ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.
Receive News & Stock Ratings for ConvaTec Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group PLC and related stocks with our FREE daily email newsletter.